Skip to content
POM-V Prescription Required Companion Animal

Carprofelican 50 mg/ml Solution for Injection for Dogs and Cats

Active ingredient: Carprofen

Form

Injection

Species

Cats Dogs

Manufacturer

Le Vet Beheer B.V.

VMD MA No.

41821/5007

What it's used for

Dogs: for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intra-ocular) surgery. Cats: for the control...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Carprofen

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Carprofelican 50 mg/ml Solution for Injection for Dogs and Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Dogs: for the control of post-operative pain and inflammation following orthopaedic and
soft tissue (including intra-ocular) surgery.
Cats: for the control of post-operative pain following surgery.
Do not use in animals suffering from cardiac, hepatic or renal disease or gastrointestinal
problems, where there is a possibility of gastrointestinal ulceration or bleeding.
Do not use in cases of hypersensitivity to the active substance or any other NSAIDs (non-
steroidal anti-inflammatory drugs) or to any of the excipients.
Do not administer by intramuscular injection.
Do not use after surgery which was associated with considerable blood loss.
Do not use in cats on repeated occasions.
Do not use in cats less than 5 months of age.
Do not use in dogs less than 10 weeks of age.

Revised January 2024
AN: 03387/2022Page 2 of 6
See also section 4.7, as the veterinary medicinal product is contraindicated during
pregnancy and lactation.
Dogs and cats
Rare
(1 to 10 animals / 10,000
animals treated)
Injection site reaction
aVery rare
(<1 animal / 10,000 animals
treated, including isolated
reports)
Vomiting
bc
, diarrhoea
bc
, loose stool
bc
, blood in
faeces
bc
appetite loss
bc
, lethargy
b
Undetermined frequency
(cannot be estimated from the
available data)
Vomiting
bd
, diarrhoea
bd
, loose stool
bd
, blood in
faeces
bd
appetite loss
bd

Revised January 2024
AN: 03387/2022Page 3 of 6
a
following subcutaneous injection
b
most cases are transient and disappear following termination of the treatment but in very
rare cases may be serious or fatal
c
In Dogs only.
d
In Cats only.
As with other NSAIDs there is a risk of rare renal, idiosyncratic hepatic or gastro-intestinal
tract adverse events.
If adverse reactions occur, use of the veterinary medicinal product should be stopped and
the advice of a veterinarian should be sought.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
None.

Special precautions for use in animals
Do not exceed the recommended dose or duration of treatment.
Due to the longer half-life in cats and narrower therapeutic index, particular care should be
taken not to exceed the recommended dose and the dose should not be repeated.

Use in aged dogs and cats, may involve additional risk. If such use cannot be avoided,
such animals may require a reduced dosage and careful clinical management.
Avoid use in dehydrated, hypovolaemic or hypotensive animals, as there is a potential risk
of increased renal toxicity.
NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory
conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy
should be instigated.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to carprofen should avoid contact with the veterinary
medicinal product.
Care should be taken to avoid accidental self-injection. In case of accidental self-injection
seek medical advice immediately and show the package leaflet or the label to the
physician.
Carprofen, in common with other NSAIDs, has been shown to exhibit photosensitising
potential in laboratory studies.
Avoid contact with skin and eyes. Wash off any splashes immediately with clean, running
water.
Seek medical attention if irritation persists.
Carprofen should not be administered concurrently, or within 24 hours of another NSAID,
or in conjunction with glucocorticosteroids. Carprofen is highly bound to plasma proteins
and may compete with other highly bound drugs which can lead to toxic effects. Hence,
concurrent administration with potentially nephrotoxic drugs should be avoided.
Store in a refrigerator (2C - 8C). Do not freeze.
Keep the vial in the outer carton in order to protect from light.
For the full list of excipients, see section

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.